Skyhawk Therapeutics has announced positive interim results from its phase 1 trial of SKY-0515, an investigational treatment for Huntington’s disease. The phase 1 clinical trial of SKY-0515 showed ...

A small Cessna plane flipped during a takeoff attempt at the Augusta Municipal Airport on Saturday morning. The sole occupant, a pilot from Wichita, was not injured. A single-engine 2023 Cessna ...

ALBANY, NY (WRGB) — A safe landing at the Albany Airport Saturday morning. Just after 10 am, a Skyhawk 172 alerted Albany International Airport traffic control tower it had a frozen fuel line. The ...

Seagate is extending its mass-capacity hard drive lineup with 32TB CMR models across three established product families: Exos, SkyHawk AI, and IronWolf Pro. The company’s announcement is dated January ...

The world of drone technology has rapidly evolved in recent years, bringing cutting-edge innovation into the hands of hobbyists, professionals, and tech enthusiasts alike. Among the rising stars of ...

Skyhawk residents are pushing back against a proposal to quadruple the number of beds at a recovery center in the northeast Santa Rosa neighborhood. Pura Vida Recovery Services currently operates a ...

We all once believed that owning a drone is not something you do impulsively or without proper financial planning. It's either you go for a cheap fake drone or you go for an expensive high-quality ...

Peter earned a Bachelor of Archeology and Creative Writing from the University of Alabama and has since joined his love of driving and riding with storytelling. His voice is full of southern ...

Matt Nelson is an automotive journalist with nearly a decade of experience in all things cars. He's spent years working at dealerships in sales, finance, and service. He's since traded in his pens and ...

SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral dose Treatment with SKY-0515 also results in important dose-dependent ...

BOSTON, Sept. 17, 2025 /PRNewswire/ -- Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets, today ...